You have full text access to this OnlineOpen article

Chlamydia pneumoniae infection of aortic smooth muscle cells reduces platelet-derived growth factor receptor-β expression

  1. Jürgen Rödel1,
  2. Marc Lehmann2,
  3. Heinz Vogelsang3,
  4. Eberhard Straube1

Article first published online: 29 AUG 2007

DOI: 10.1111/j.1574-695X.2007.00312.x

Issue

FEMS Immunology & Medical Microbiology

FEMS Immunology & Medical Microbiology

Volume 51, Issue 2, pages 363–371, November 2007

Additional Information

How to Cite

Rödel, J., Lehmann, M., Vogelsang, H. and Straube, E. (2007), Chlamydia pneumoniae infection of aortic smooth muscle cells reduces platelet-derived growth factor receptor-β expression. FEMS Immunology & Medical Microbiology, 51: 363–371. doi: 10.1111/j.1574-695X.2007.00312.x

Author Information

  1. 1

    Institute of Medical Microbiology, Friedrich Schiller University of Jena, Jena, Germany

  2. 2

    SIRS-Lab GmbH, Jena, Germany

  3. 3

    Institute of Clinical Chemistry and Laboratory Diagnostics, Friedrich Schiller University of Jena, Jena, Germany

*Correspondence: Jürgen Rödel, Institute of Medical Microbiology, Friedrich Schiller University of Jena, Semmelweisstr. 4, D-07740 Jena, Germany. Tel.: +49 3641 933905; fax: +49 3641 933474; e-mail: juergen.roedel@med.uni-jena.de

  1. Editor: Patrik Bavoil

Publication History

  1. Issue published online: 29 AUG 2007
  2. Article first published online: 29 AUG 2007
  3. Received 10 April 2007; revised 10 July 2007; accepted 10 July 2007.First published online October 2007.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (203K)

References

  • Abe J, Deguchi J, Takuwa Y, Hara K, Ikari Y, Tamura T, Ohno M & Kurokawa K (1998) Tyrosine phosphorylation of platelet-derived growth factor β receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris. Heart 79: 400–406.
  • Aidinian G, Weiswasser JM, Arora S, Abularrage CJ, Singh N & Sidaway AN (2006) Carotid plaque morphologic characteristics. Pers Vasc Surg Endovasc Ther 18: 63.
  • Basciani S, Mariani S, Arizzi M et al. (2002) Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-α and -β during human testicular development and disease. J Clin Endocrinol Metab 87: 2310–2319.
  • Belland RJ, Ouellette SP, Gieffers J & Byrne GI (2004) Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 6: 117–127.
    Direct Link:
  • Cannon CP, Braunwald E, McCabe CH, Grayston JT, Muhlestein B, Giugliano RP, Cairns R, Skene AM & For the Pravastatin or Atorvastatin Evaluation and Infection Therapy – Thrombolysis in Myocardial Infarction 22 Investigators (2005) Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 352: 1646–1654.
  • Coombes BK, Chiu B, Fong IW & Mahony JB (2002) Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis. J Infect Dis 185: 1621–1630.
  • Dechend R, Gieffers J, Dietz R, Joerres A, Rupp J, Luft FC & Maass M (2003) Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation. Circulation 108: 261–265.
  • Ezzahiri R, Stassen FRM, Kurvers HAJM, Van Pul MML, Kitslaar PJEHM & Bruggeman CA (2003) Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL receptor, ApoE double knockout mice. Eur J Vasc Endovasc Surg 26: 88–95.
  • Grayston JT, Kronmal RA, Jackson LA et al. (2005) Azithromycin for the secondary prevention of coronary events. N Engl J Med 352: 1637–1645.
  • Hauer AD, De Vos P, Peterse N, Ten Cate H, Van Berkel TJC, Stassen FRM & Kuiper J (2006) Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr−/− mice. Cardiovasc Res 69: 280–288.
  • Huber W, Von Heydebreck A, Sueltmann H, Poustka A & Vingron M (2003) Parameter estimation for the calibration and variance stabilization of microarray data. Statist Appl Genet Mol Biol 2: 3.
  • Ieven MM & Hoymans VY (2005) Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 43: 19–24.
  • Kozaki K, Kaminski WE, Tang J et al. (2002) Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. Am J Pathol 161: 1395–1407.
  • De Kruif MD, Van Gorp ECM, Keller TT, Ossewarde JM & Ten Cate H (2005) Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research. Cardiovasc Res 65: 317–327.
  • Kuo CC, Gown AM, Benditt EB & Grayston JT (1993) Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 13: 1501–1504.
  • Lafont A (2003) Basic aspects of plaque vulnerability. Heart 89: 1262–1267.
  • Libby P (1995) Molecular bases of the acute coronary syndrome. Circulation 91: 2844.
  • Prochnau D, Rödel J, Hartmann M, Straube E & Figulla HR (2004) Growth factor production in human endothelial cells after Chlamydia pneumoniae infection. Int J Med Microbiol 294: 53–57.
  • Raines EW (2004) PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15: 237–254.
  • Reinhardt B, Mertens T, Mayr-Beyrle U, Frank H, Lüske A, Schierling K & Waltenberger J (2005) HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF β-receptor. Cardiovasc Res 67: 151–160.
  • Rödel J, Woytas M, Groh A, Schmidt KH, Hartmann M, Lehmann M & Straube E (2000) Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect Immun 68: 3635–3641.
  • Rödel J, Prochnau D, Prager K, Pentcheva E, Hartmann M & Straube E (2003) Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae. FEMS Immunol Med Microbiol 38: 159–164.
    Direct Link:
  • Rödel J, Prochnau D, Prager K, Baumert J, Schmidt KH & Straube E (2004) Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis. Infect Immun 72: 4900–4904.
  • Rolfs A, Schuller I, Finckh U & Weber-Rolfs I (1992) PCR: Clinical Diagnostics and Research, pp. 102–107. Springer, Berlin.
  • Ross R (1999) Atherosclerosis-an inflammatory disease. New Engl J Med 340: 115–126.
  • Rubin K, Tingstrom A, Hansson GK, Larsson E, Ronnstrand L, Klareskog L, Claesson-Welsh L, Heldin CH, Fellstrom B & Terracio L (1988) Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet 1: 1353–1356.
  • Sano H, Sudo T, Yokode M, Murayama T, Kataoka H, Takakura N, Nishikawa S, Nishikawa SI & Kita T (2001) Functional blockade of platelet-derived growth factor receptor-β but not of receptor-α prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation 103: 2955–2960.
  • Sasu S, La Verda D, Qureshi N, Golenbock DT & Beasley D (2001) Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 89: 244–250.
  • Shor A, Phillips JI, Ong G, Thomas BJ & Taylor-Robinson D (1998) Chlamydia pneumoniae in atheroma: consideration of criteria for causality. J Clin Pathol 51: 812–817.
  • Wang AM, Doyle MV & Mark DF (1989) Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86: 9717–9721.
  • Weber C, Schober A & Zernecke A (2004) Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 24: 1997–2008.
  • Yang X, Coriolan D, Schultz K, Golenbock DT & Beasley D (2005) Toll-like receptor 2 mediates persistent chemokine release by Chlamydiapneumoniae-infected vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 25: 2308–2314.
View Full Article (HTML) Get PDF (203K)